# LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

> **NCT00412997** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 14 (actual)

## Conditions studied

- Tumors
- Cutaneous T-Cell Lymphoma

## Interventions

- **DRUG:** LBH589

## Key facts

- **NCT ID:** NCT00412997
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-05
- **Final completion:** —
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412997, "LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00412997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*